Good Morning Gumnut,
Would you mind casting your eye over the press release from a French pharma Erytech. They have released their phase 3 results which have fallen to some extent to reach end points.
I'm interested in the references to the chemo drugs gemcirabine and ironotecan and how this outcome may benefit SPL and spotlight the DEP platform.
I'm without a computer this week as I'm off site...so hard to read on phone.
Thank you in advance
- Forums
- ASX - By Stock
- DEP phase 2 trials - patience required!
Good Morning Gumnut, Would you mind casting your eye over the...
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 586785 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 56840 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 586785 | 0.095 |
2 | 10000 | 0.094 |
1 | 28393 | 0.093 |
1 | 50000 | 0.092 |
2 | 16000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 56840 | 1 |
0.100 | 8705 | 2 |
0.105 | 96531 | 4 |
0.110 | 39609 | 6 |
0.115 | 138531 | 6 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online